Minireview: CRF and Wylie Vale: A Story of 41 Amino Acids and a Texan with Grit
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
“Resilience is critical in all things. Grit and zest are qualities most predictive of success.” The structure and full chemical and biological characterization of ovine corticotropin-releasing factor (oCRF) was reported in 1981 by Wylie W. Vale and colleagues working at the Salk Institute (La Jolla, CA) in temporary barracks located west of the main building of the Salk Institute with a full view of the Pacific (1). It was an extraordinary time in the field of endocrinology, and the competition for discovery was fierce. The climate at the Salk, where the superstars of today (including George Koob, Catherine and Jean Rivier, Paul Sawchenko, and Wylie Vale) were being trained by remarkable leaders in science (Larry Swanson, Floyd Bloom, and Roger Guillemin), was no different. One trainee in particular, Wylie Vale, stood out as a resilient and strong-willed young scientist, passionate about isolating CRF. Having come to Salk initially as a postdoctoral fellow of Roger Guillemin's in 1970, Wylie was a Texan thrust into Southern California at a time when surf boards and palm trees still outnumbered residents. “It was like a scientific playground,” described George Koob, “the Salk Institute was full of passion and energy. We'd get together and play intensely competitive racquetball or tennis in the morning before heading into the lab — where that competition to make the next big breakthrough continued.” The search for CRF, over the next 30 yr, took Wylie and his colleagues on an intriguing journey that none of them could have predicted. From the race to elucidate its unpredicted sequence to identifying its unimaginable central effects on behavior, CRF (similar to the man who led the search for its identification) turned out to be a pretty remarkable story. In 1969, Roger Guillemin's lab at the Baylor School of Medicine (Houston, TX) was searching for hypothalamic-releasing hormones. At that time, Wylie Vale was a postdoc working on a project searching for TSH-releasing factor (TRF) and other hypothalamic releasing factors (2, 3). Also present in Houston was a young graduate student, Catherine Rivier, who had moved from her native Switzerland with her husband, Jean Rivier, to do her graduate work in Guillemin's lab, bringing with her a requested allotment of ACTH antibody, with which she would later develop the first bioassay for CRF in rodents. “Wylie helped us to adjust and introduced us to the Texan way of life by taking us to rodeos and teaching us the local vernacular. He was always so thoughtful,” commented Catherine. Endocrine physiology research in the late 1960s was far different than it is today. To determine what effect TRF had on the body, Wylie himself was injected with it (under medical supervision). Certainly not something we would think about doing today. “It felt like you were going to die — you wet your pants, your heart raced, you become very light-sensitive!” Catherine recalls Wylie's description. “It was an incredibly powerful, but short-lived experience.” This would turn out to be some of the first major evidence that these hypothalamic hormones had central nervous system effects. Shortly thereafter, Guillemin accepted an offer and moved his lab to the Salk Institute in 1970. Wylie's focus turned to CRF after arriving at the Salk, declaring to his young mentee, Catherine, “Now, we are working on isolating CRF.” And that is exactly what they did. Working night and day, and even working through the night on many occasions, Catherine, Jean, and Wylie were obsessed with finding this peptide. The three scientists had separated from Guillemin by this point and were working in the temporary space out near the parking lot. It was less than a glamorous location, but one that they had been given as their own lab space by the Salk president, Frederic de Hoffman. Although Guillemin retained the aqueous extracts from the half million sheep hypothalami, Wylie had been given access to the original hydrophobic fraction from the petroleum ether extracts where everyone presumed it would be much less likely CRF would be found. Less likely. But not impossible. This became a labor of love, and a story of incredible perseverance and elbow grease. “After working night and day for hours and hours on these extracts, we smelled so bad that people in the supermarket would run away,” recalled Catherine. To determine whether they had the correct CRF-containing fraction, Catherine would infuse the sample into anesthetized rats and then measure plasma ACTH 10–15 min later. Nothing worked. Little did they know that CRF was a much larger and stickier peptide hormone than known peptides, such as TRF, GnRH, somatostatin, arginine vasopressin (AVP), or oxytocin, “It stuck to everything!” explained Catherine, “the glassware, the tubes, the chromatographic supports, everything.” Because they were already working with the ether extract samples containing lower concentrations of the hormone, frustration was around every corner. Thr
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 1×
“In fact, it was during this time that clinical studies investigating stress dysregulation in mental health disorders discovered elevated CRF levels in the CSF of depressed patients, launching a new era focusing drug targets in pharmaceutical treatment of affective disorders and other stress-related diseases (11, 12).”
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Self-citationLewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · cited 2×
“And indeed after the completion of the genome project, Wylie and his team found two more ligands, Ucn2 and Ucn3 (29, 30).”
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887 · cited 2×
“And indeed after the completion of the genome project, Wylie and his team found two more ligands, Ucn2 and Ucn3 (29, 30).”
Henry, B., Vale, W., & Markou, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1494-06.2006 · Cited by 147
Cited by
A users guide to HPA axis research
Spencer, R. L., & Deak, T. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.11.014 · Cited by 405
Myers, B., McKlveen, J. M., & Herman, J. P. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.12.003 · Cited by 318
Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170224095741 · Cited by 147
“After decades of intensive research, Wylie Vale (Guillemin’s former PhD’s student) [2] and his colleagues made a series of milestone discoveries.”
BackgroundThe physiological roles of placental corticotropin releasing hormone in pregnancy and childbirth
Thomson, M. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0227-2 · Cited by 107
The CRF system as a therapeutic target for neuropsychiatric disorders
Sanders, J., & Nemeroff, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.004 · Cited by 72
Metadata
- Authors
- Bale, T. L., & Chen, A.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2012-04-16
- Volume
- 153
- Issue
- 6
- Pages
- 2556-2561
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2001407446
- Cited by
- 23
- References
- 5
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.